Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Global World News Controlling Mpox Requires Inclusive, Global Efforts is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Mpox no longer a global health emergency, WHO says
Mpox is no longer a global public health emergency, the World Health Organization (WHO) has said. The agency declared mpox a Public Health Emergency of International Concern (PHEIC) in August 2024 ... Read More
WHO declares end of global emergency over mpox outbreak
The African mpox outbreak no longer constitutes a public health emergency of international concern, the WHO said, even as the response must continue. Read More
Ministry Bolsters Efforts to Control Mpox Virus

Addis Ababa, May 28, 2025 (ENA)— Efforts are intensified to control the spread of Mpox virus, which was detected in Moyale of Oromia Region of Ethiopia. Mpox is a viral disease, previously known as ... Read More
Monkeypox: One Year After Global Alert, WHO Says Mpox Is No Longer An Emergency
Mpox was first declared an emergency in August last year, when an outbreak of a new form of mpox started to spread from the worst-hit Democratic Republic of Congo to neighbouring countries. Read More
WHO Extended Global Emergency Status of MPox Epidemic – Development of Treatment for MPox with NV-387 is Timely, Says NanoViricides

SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the ... Read More
GeoVax Accelerates Development of GEO-MVA Vaccine Amid Expanding Global Mpox Crisis and Reaffirmed WHO Emergency Designation

ATLANTA, GA - July 29, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing multi-antigenic vaccines and immunotherapies against infectious diseases and cancer, ... Read More
Blow Us A Whistle

Comments (Whistles) Designed By Disqus